EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CXCL13 as a Biomarker: Background and Utility in Multiple Sclerosis

Andrew R Pachner, Steven Pike iD, Andrew D Smith, Francesca Gilli

Biomolecules · 30.11.2024 · 14 (12) · 1541

DOI: 10.3390/biom14121541 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 30.11.2024. Verfasst von Andrew R Pachner und 3 weiteren Autor:innen. Beteiligte Einrichtung: Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA. Hauptthemen laut MEDLINE: Chemokine CXCL13, Multiple Sclerosis, Biomarkers. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bornstein Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CXCL13 is a chemokine which is upregulated within the CNS in multiple sclerosis, Lyme neuroborreliosis, and other inflammatory diseases and is increasingly clinically useful as a biomarker. This review provides background for understanding its function in the immune system and its relationship to ectopic lymphoid follicles. Also reviewed are its utility in multiple sclerosis and Lyme neuroborreliosis and potential problems in its measurement. CXCL13 has the potential to be an exceptionally useful biomarker in a range of inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemokine CXCL13Multiple SclerosisBiomarkersHumansLyme NeuroborreliosisAnimals

Stichwörter der Autor:innen

CXCL13ELISALuminexLyme neuroborreliosisOlinkchemoattractantchemokineectopic lymphoid folliclematrix effectsmultiple sclerosispoint-of-care testing

Substanzen

Chemokine CXCL13BiomarkersCXCL13 protein, human

Autor:innen und Institutionen

  • Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA.

ORCID-Profile: Steven Pike

Förderung

  • Bornstein Research Fund

Zitieren

APA

Pachner, A. R., Pike, S., Smith, A. D., & Gilli, F. (2024). CXCL13 as a Biomarker: Background and Utility in Multiple Sclerosis. Biomolecules, 14(12), 1541. https://doi.org/10.3390/biom14121541

Vancouver

Pachner AR, Pike S, Smith AD, Gilli F. CXCL13 as a Biomarker: Background and Utility in Multiple Sclerosis. Biomolecules. 2024;14(12):1541. doi:10.3390/biom14121541

BibTeX
@article{Pachner2024,
  author = {Pachner, Andrew R and Pike, Steven and Smith, Andrew D and Gilli, Francesca},
  title = {CXCL13 as a Biomarker: Background and Utility in Multiple Sclerosis},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {12},
  pages = {1541},
  doi = {10.3390/biom14121541}
}
Kostenlos starten →